Ribas A - Search Results

1

Quantitative PET reporter gene imaging of CD8+ T cells specific for a melanoma-expressed self-antigen.

Shu CJ, Radu CG, Shelly SM, Vo DD, Prins R, Ribas A, Phelps ME, Witte ON. Shu CJ, et al. Among authors: ribas a. Int Immunol. 2009 Feb;21(2):155-65. doi: 10.1093/intimm/dxn133. Epub 2008 Dec 23. Int Immunol. 2009. PMID: 19106231 Free PMC article.

2

Generation of melanoma-specific cytotoxic T lymphocytes by dendritic cells transduced with a MART-1 adenovirus.

Butterfield LH, Jilani SM, Chakraborty NG, Bui LA, Ribas A, Dissette VB, Lau R, Gamradt SC, Glaspy JA, McBride WH, Mukherji B, Economou JS. Butterfield LH, et al. Among authors: ribas a. J Immunol. 1998 Nov 15;161(10):5607-13. J Immunol. 1998. PMID: 9820539

3

Fine specificity analysis of an HLA-A2.1-restricted immunodominant T cell epitope derived from human alpha-fetoprotein.

Meng WS, Butterfield LH, Ribas A, Heller JB, Dissette VB, Glaspy JA, McBride WH, Economou JS. Meng WS, et al. Among authors: ribas a. Mol Immunol. 2000 Nov;37(16):943-50. doi: 10.1016/s0161-5890(01)00017-7. Mol Immunol. 2000. PMID: 11395133

4

CD40 cross-linking bypasses the absolute requirement for CD4 T cells during immunization with melanoma antigen gene-modified dendritic cells.

Ribas A, Butterfield LH, Amarnani SN, Dissette VB, Kim D, Meng WS, Miranda GA, Wang HJ, McBride WH, Glaspy JA, Economou JS. Ribas A, et al. Cancer Res. 2001 Dec 15;61(24):8787-93. Cancer Res. 2001. PMID: 11751400

5

Immunosuppressive effects of interleukin-12 coexpression in melanoma antigen gene-modified dendritic cell vaccines.

Ribas A, Amarnani SN, Buga GM, Butterfield LH, Dissette VB, McBride WH, Glaspy JA, Ignarro LJ, Economou JS. Ribas A, et al. Cancer Gene Ther. 2002 Nov;9(11):875-83. doi: 10.1038/sj.cgt.7700512. Cancer Gene Ther. 2002. PMID: 12386826

6

Enhanced tumor responses to dendritic cells in the absence of CD8-positive cells.

Ribas A, Wargo JA, Comin-Anduix B, Sanetti S, Schumacher LY, McLean C, Dissette VB, Glaspy JA, McBride WH, Butterfield LH, Economou JS. Ribas A, et al. J Immunol. 2004 Apr 15;172(8):4762-9. doi: 10.4049/jimmunol.172.8.4762. J Immunol. 2004. PMID: 15067052

7

Ionizing radiation affects human MART-1 melanoma antigen processing and presentation by dendritic cells.

Liao YP, Wang CC, Butterfield LH, Economou JS, Ribas A, Meng WS, Iwamoto KS, McBride WH. Liao YP, et al. Among authors: ribas a. J Immunol. 2004 Aug 15;173(4):2462-9. doi: 10.4049/jimmunol.173.4.2462. J Immunol. 2004. PMID: 15294960

8

Natural killer cells play a critical role in the immune response following immunization with melanoma-antigen-engineered dendritic cells.

Wargo JA, Schumacher LY, Comin-Anduix B, Dissette VB, Glaspy JA, McBride WH, Butterfield LH, Economou JS, Ribas A. Wargo JA, et al. Among authors: ribas a. Cancer Gene Ther. 2005 Jun;12(6):516-27. doi: 10.1038/sj.cgt.7700818. Cancer Gene Ther. 2005. PMID: 15775996

9

Broad antitumor protection by dendritic cells administered to CD8alpha knock out mice.

Ribas A, Vo DD, Weeks DL, Comin-Anduix B, Schumacher LY, Garban HJ, McLean C, Yang J, Dissette VB, Peraza P, Owens SK, McBride WH, Glaspy JA, Economou JS. Ribas A, et al. Cancer Immunol Immunother. 2006 Jun;55(6):663-71. doi: 10.1007/s00262-005-0065-y. Epub 2005 Aug 13. Cancer Immunol Immunother. 2006. PMID: 16133107

10

Immunosensitization of tumor cells to dendritic cell-activated immune responses with the proteasome inhibitor bortezomib (PS-341, Velcade).

Schumacher LY, Vo DD, Garban HJ, Comin-Anduix B, Owens SK, Dissette VB, Glaspy JA, McBride WH, Bonavida B, Economou JS, Ribas A. Schumacher LY, et al. Among authors: ribas a. J Immunol. 2006 Apr 15;176(8):4757-65. doi: 10.4049/jimmunol.176.8.4757. J Immunol. 2006. PMID: 16585569

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

717 results

Search Page